[A case of Parkinson's disease with marked head drop after administration of donepezil hydrochloride].

Q4 Medicine
Clinical Neurology Pub Date : 2024-09-26 Epub Date: 2024-08-24 DOI:10.5692/clinicalneurol.cn-001983
Keisuke Hara, Eito Miura, Yoshitaka Umeda, Maiko Umeda, Mutsuo Oyake, Nobuya Fujita
{"title":"[A case of Parkinson's disease with marked head drop after administration of donepezil hydrochloride].","authors":"Keisuke Hara, Eito Miura, Yoshitaka Umeda, Maiko Umeda, Mutsuo Oyake, Nobuya Fujita","doi":"10.5692/clinicalneurol.cn-001983","DOIUrl":null,"url":null,"abstract":"<p><p>A 76-year-old woman with a 2-year history of Parkinson's disease presented with dropped head, which had developed rapidly after she had been prescribed donepezil hydrochloride (DNP) at 3 ‍mg/day. After one month of medication, the extent of the head drop reached 90°. Examination revealed hypertrophy of the left sternocleidomastoid muscle, but no weakness of the extensor muscles in the cervical region. Surface electromyography demonstrated co-‍contraction of the sternocleidomastoid and splenius capitus muscles during head flexion and extension. DNP was withdrawn, resulting in immediate amelioration of the head drop, and complete resolution was achieved after two months. Although head drop is often seen in patients with Parkinson's disease, few previous reports have documented DNP as a causative factor. If patients with Parkinson's disease develop head drop, it is important to investigate any history of DNP medication.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":"664-667"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5692/clinicalneurol.cn-001983","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

A 76-year-old woman with a 2-year history of Parkinson's disease presented with dropped head, which had developed rapidly after she had been prescribed donepezil hydrochloride (DNP) at 3 ‍mg/day. After one month of medication, the extent of the head drop reached 90°. Examination revealed hypertrophy of the left sternocleidomastoid muscle, but no weakness of the extensor muscles in the cervical region. Surface electromyography demonstrated co-‍contraction of the sternocleidomastoid and splenius capitus muscles during head flexion and extension. DNP was withdrawn, resulting in immediate amelioration of the head drop, and complete resolution was achieved after two months. Although head drop is often seen in patients with Parkinson's disease, few previous reports have documented DNP as a causative factor. If patients with Parkinson's disease develop head drop, it is important to investigate any history of DNP medication.

[一例服用盐酸多奈哌齐后头部明显下垂的帕金森病患者]。
一位 76 岁的妇女患有帕金森病,病史长达 2 年,在服用 3 ‍mg/ 天剂量的盐酸多奈哌齐(DNP)后,头部迅速下垂。服药一个月后,头部下垂的程度达到了 90°。检查发现左侧胸锁乳突肌肥大,但颈部伸肌没有无力感。表面肌电图显示,在头部屈曲和伸展时,胸锁乳突肌和脾岬肌共同收缩。停用 DNP 后,垂头症状立即得到改善,两个月后完全缓解。虽然帕金森病患者经常出现头部下垂,但以前很少有报告称 DNP 是致病因素。如果帕金森病患者出现头下垂,必须调查是否有服用 DNP 的病史。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Neurology
Clinical Neurology Medicine-Neurology (clinical)
CiteScore
0.30
自引率
0.00%
发文量
147
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信